{'Year': '2018', 'Month': 'Jun'}
Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation.
This study aimed to analyse the effects of genetic polymorphisms in drug transporters and metabolizing enzymes, and clinical laboratory data on the pharmacokinetic parameters of apixaban.